7674 Journal of Medicinal Chemistry, 2005, Vol. 48, No. 24
Mart´ın-Martı´nez et al.
(16) Low, C. M. R.; Black, J. W.; Broughton, H. B.; Buck, I. M.;
Davies, J. M. R.; Dunstone, D. J.; Hull, R. A. D.; Kalindjian, S.
B.; McDonald, I. M.; Pether, M. J.; Shankley, N. P.; Steel, K. I.
M. Development of peptide 3D structure mimetics: Rational
design of novel peptoid cholecystokinin receptor antagonists. J.
Med. Chem. 2000, 43, 3505-3517.
(17) Horwell, D. C.; Beeby, A.; Clark, C. R.; Hughes, J. Synthesis
and binding affinities of analogues of cholecystokinin-(30-33)
as probes for central nervous system cholecystokinin receptors.
J. Med. Chem. 1987, 30, 729-732.
(26) Holladay, M. W.; Bennett, M. J.; Bai, H.; Ralston, J. W.; Kerwin,
J. F., Jr.; Stashko, M.; Miller, T. R.; O’Neil, A. B.; Nadzan, A.
M.; Brioni, J.; Lin, C. W. Amino acid-derived piperidines as novel
CCKB ligands with anxiolytic-like properties. Bioorg. Med. Chem.
Lett. 1995, 5, 3057-3062.
(27) Kalindjian, S. B.; Buck, I. M.; Cushnir, J. R.; Dunstone, D. J.;
Hudson, M. L.; Low, C. M. R.; McDonald, I. M.; Pether, M. J.;
Steel, K. I. M.; Tozer, M. J. Improving the affinity and selectivity
of a nonpeptide series of cholecystokinin-B/gastric receptor
antagonists based on the dibenzobicyclo[2.2.2]octane skeleton.
J. Med. Chem. 1995, 38, 4294-4302.
(28) Gonza´lez-Mun˜iz, R.; Dom´ınguez, M. J.; Mart´ın-Mart´ınez, M.;
Herranz, R.; Garc´ıa-Lo´pez, M. T.; Barber, A.; Ballaz, S.; Del Rio,
J. CCK-4 restricted analogues containing a 3-oxoindolizidine
skeleton. Bioorg. Med. Chem. Lett. 1996, 6, 967-972.
(29) Mart´ın-Mart´ınez, M.; Bartolome´-Nebreda, J. M.; Go´mez-Monter-
rey, I.; Gonza´lez-Mun˜iz, R.; Garc´ıa-Lo´pez, M. T.; Ballaz, S.;
Barber, A.; Fortun˜o, A.; Del Rio, J.; Herranz, R. Synthesis and
stereochemical structure-activity relationships of 1,3-dioxop-
erhydropyrido[1,2-c]pyrimidine derivatives: Potent and selective
cholecystokinin-A receptor antagonists. J. Med. Chem. 1997, 40,
3402-3407.
(30) Kolodziej, S. A.; Nikiforovich, G. V.; Skeean, R.; Lignon, M.-F.;
Mart´ınez, J.; Marshall, G. R. Ac-[3- and 4- Alkylthioproline31]-
CCK4 analogs: Synthesis and implications for the CCK-B
receptor-bound conformation. J. Med. Chem. 1995, 38, 137-149.
(31) (a) Fournie-Zaluski, M. C.; Belleney, J.; Lux, B.; Durieux, C.;
Gerard, D.; Maigret, B.; Roques, B. P. Conformational analysis
of cholecystokinin CCK26-33 and related fragments by 1H NMR
spectroscopy, fluorescence-transfer measurements and calcula-
tions. Biochemistry 1986, 25, 3778-3787. (b) Kreissler, M.;
Pesquer, M.; Maigret, B.; Fournie-Zaluski, M. C.; Roques, B. P.
Computer simulation of the conformational behavior of chole-
cystokinin fragments: Conformational families of sulfated CCK8.
J. Computer-Aided Mol. Des. 1989, 3, 85-94.
(32) Nikiforovich, G.; Hruby, V. J. Models for the A- and B-receptor-
bound conformations of CCK-8. J. Biochem. Biophys. Res.
Commun. 1993, 194, 9-16.
(33) Hurby, V. J.; Fang, S.; Knapp, R.; Kazmierski, W.; Lui, G. K.;
Yamamura, H. I. Cholecystokinin analogues with high affinity
and selectivity for brain membrane receptors. Int. J. Pept.
Protein Res. 1990, 35, 566-573.
(34) Nagai, U.; Sato, K. Synthesis of bicyclic dipeptide with the shape
of â-turn-central part. Tetrahedron Lett. 1985, 5, 647-650.
(35) Sato, K.; Nagai, U. Synthesis and antibiotic activity of a
gramicidine S analogue containing bicyclic â-turn dipeptides. J.
Chem. Soc., Perkin Trans. 1 1986, 1231-1234.
(36) Bach, A. C., II; Markwalder, J. A.; Ripka, W. C. Synthesis and
NMR conformational analysis of a â-turn mimic incorporated
into gramicidin S. Int. J. Pept. Protein Res. 1991, 38, 314-323.
(37) Kessler, H. Conformation and biological activity of cyclic pep-
tides. Angew. Chem., Int. Ed. Engl. 1982, 21, 512-523.
(38) Meyer, E. A.; Castellano, R. K.; Diederich, F. Interaction with
aromatic rings in chemical and biological recognition. Angew.
Chem., Int. Ed. 2003, 42, 1211-1250.
(18) (a) Higginbottom, M.; Horwell, D. C.; Roberts, E. Selective
ligands for cholecystokinin receptor subtypes CCK-A and CCK-B
within a single structural class. Bioorg. Med. Chem. Lett. 1993,
3, 881-884. (b) Boden, P. R.; Higginbottom, M.; Hill, D. R.;
Horwell, D. C.; Hughes, J.; Rees, D. C.; Roberts, E.; Singh, L.;
Suman-Chauhan, N.; Woodruff, G. N. Cholecystokinin dipeptoid
antagonists: Design, synthesis, and anxiolytic profile of some
novel CCK-A and CCK-B selective and mixed CCK-A/CCK-B
antagonists. J. Med. Chem. 1993, 36, 552-565. (c) Boden, P.
R.; Eden, J. M.; Higginbottom, M.; Hill, D. R.; Horwell, D. C.;
Hunter, J. C.; Martin, K.; Pritchard, M. C.; Richardson, M. C.;
Roberts, E. Rational designed dipeptoid analogues of cholecys-
tokinin (CCK): C-Terminal structure-activity relationships of
R-methyl tryptophan derivatives. Eur. J. Med. Chem. 1993, 28,
47-61. (d) Padia, J. K.; Bolton, G. L.; Hill, D.; Horwell, D. C.;
Roth, B. D.; Trivedi, B. K. Synthesis and SAR studies of novel
CCK-B antagonists. Bioorg. Med. Chem. Lett. 1993, 3, 2805-
2810. (e) Blommaert, A. G. S.; Weng, J.-H.; Dorville, A.; McCort,
I.; Ducos, B.; Durieux, C.; Roques, B. P. Cholecystokinin pepti-
domimetics as selective CCK-B antagonists: Design, synthesis
and in vitro and in vivo biochemical properties. J. Med. Chem.
1993, 36, 2868-2877. (f) Trivedi, B. K.; Padia, J. K.; Holmes,
A.; Rose, S.; Wright, D. S.; Hinton, J. P.; Pritchard, M. C.; Eden,
J. M.; Kneen, C.; Webdale, L.; Suman-Chauhan, N.; Boden, P.;
Singh, L.; Field, M. J.; Hill, D. Second generation peptoid
CCK-B receptor antagonists: Identification and development
of N-(adamantyloxycarbonyl)-R-methyl-(R)-tryptophan deriva-
tive (CI-1015) with an improved pharmacokinetic profile. J. Med.
Chem. 1998, 41, 38-45.
(19) De la Figuera, N.; Alkorta, I.; Garc´ıa-Lo´pez, M. T.; Herranz, R.;
Gonza´lez-Mun˜iz, R. 2-Amino-3-oxohexahydroindolizino[8,7-b]-
indole-5-carboxylate derivatives as new scaffolds for mimicking
â-turn secondary structures. Molecular dynamics and stereose-
lective synthesis. Tetrahedron 1995, 51, 7841-7856.
(20) Andreu, D.; Ruiz, S.; Carren˜o, C.; Alsina, J.; Albericio, F.;
Jime´nez, M. A.; De la Figuera, N.; Herranz, R.; Garc´ıa-Lo´pez,
M. T.; Gonza´lez-Mun˜iz, R. IBTM-Containing gramicidin
S
analogues: Evidence for IBTM as a suitable type II′ â-turn
mimetic. J. Am. Chem. Soc. 1997, 119, 10579-10586.
(21) De la Figuera, N.; Mart´ın-Mart´ınez, M.; Herranz, R.; Garc´ıa-
Lo´pez, M. T.; Latorre, M.; Cenarruzabeitia, E.; Del R´ıo, J.;
Gonza´lez-Mun˜iz, R. Highly Constrained dipeptoid analogues
containing a type II′ â-turn mimic as novel and selective CCK-A
receptor ligands. Bioorg. Med. Chem. Lett. 1999, 9, 43-48.
(22) Mart´ın-Mart´ınez, M.; De la Figuera, N.; Latorre, M.; Herranz,
R.; Garc´ıa-Lo´pez, M. T.; Cenarruzabeitia, E.; Del R´ıo, J.; Gonza´-
lez-Mun˜iz, R. â-Turned dipeptoids as potent and selective CCK1
receptor antagonists. J. Med. Chem. 2000, 43, 3770-3777.
(23) Mart´ın-Mart´ınez, M.; Latorre, Garc´ıa-Lo´pez, M. T.; Cenarruza-
beitia, E.; Del R´ıo, J.; Gonza´lez-Mun˜iz, R. Effects of the
incorporation of IBTM â-turn mimetics into the dipeptoid CCK1
receptor agonists PD 170292. Bioorg. Med. Chem. Lett. 2002,
12, 109-112.
(39) Ballaz, S.; Barber, A.; Fortun˜o, A.; Del R´ıo, J.; Mart´ın-Mart´ınez,
M.; Go´mez-Monterrey, I.; Herranz, R.; Gonza´lez-Mun˜iz, R.;
Garc´ıa-Lo´pez, M. T. Pharmacological evaluation of IQM-95,333,
a highly selective CCK-A receptor antagonist with anxiolytic-
like activity in animal models. Br. J. Pharmacol. 1997, 121, 759-
767.
(40) Jensen, T. R.; Lemp, G. F.; Gardner, J. D. Interactions of COOH-
terminal fragments of cholecystokinin with receptors on dis-
persed acini from guinea pig pancreas. J. Biol. Chem. 1982, 257,
5554-5559.
(24) Shiosaki, K.; Craig, R.; Lin, C. W.; Barrett, R. W.; Miller, T.;
Witte, D.; Wolfram, C. A. W.; Nadzan, A. M. Torward develop-
ment of peptidomimetics: Diketopiperazine templates for the
Trp-Met segment of CCK-4. In Peptides, Chemistry, Structure
and Biology (Proceedings of the 11th American Peptide Sympo-
sium). Rivier, J. E., Marshall, G. R., Eds.; ESCOM: Leiden,
1990, pp 978-980.
(25) Flynn, D. L.; Villamil, C. I.; Becker, D. P.; Gullikson, G. W.;
Moummi, C.; Yang, D. C. 1,3,4-Trisubstituted pyrrolidinones as
scaffolds for construction of peptidomimetic cholecystokinin
antagonists. Bioorg. Med. Chem. Lett. 1992, 2, 1251-1256.
(41) Peikin, S. R.; Rottman, A. J.; Batzri, S.; Gardner, J. D. Kinetics
of amylase release by dispersed acini prepared from guinea pig
pancreas. Am. J. Physiol. 1978, 235, E743-E749.
JM050689O